Jonathan Ace Cezo Mendoza, | |
2345 Biehn St, Klamath Falls, OR 97601-1761 | |
(541) 882-4612 | |
Not Available |
Full Name | Jonathan Ace Cezo Mendoza |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2345 Biehn St, Klamath Falls, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194358986 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 60387 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jonathan Ace Cezo Mendoza, 4507 Cannon Ave Apt 27, Klamath Falls, OR 97603-6769 Ph: () - | Jonathan Ace Cezo Mendoza, 2345 Biehn St, Klamath Falls, OR 97601-1761 Ph: (541) 882-4612 |
News Archive
"Some 240,000 children have missed U.N.-backed vaccinations against polio because of security concerns in Pakistan's tribal regions bordering Afghanistan, a top official with the World Health Organization said Friday," the Associated Press/Huffington Post reports.
The Medical Research Council (MRC) and the Institute of Child Health (ICH) at UCL (University College London) have announced a partnership to establish a centre for research to improve the prevention, diagnosis and treatment of diseases affecting children's health, and to promote their health and well-being.
When crime lab chemists handle evidence that contains illegal drugs, trace amounts of those drugs are inevitably released into the laboratory environment.
Our belief as to whether we will likely succeed or fail at a given task-and the consequences of winning or losing-directly affects the levels of neural effort put forth in movement-planning circuits in the human cortex, according to a new brain-imaging study by neuroscientists at the California Institute of Technology.
"Over the past decade, neglected diseases have attracted increased attention and larger investments in research," but "a new analysis by Medecins Sans Frontieres (MSF) and the Drugs for Neglected Diseases Initiative (DNDi) finds that the rate of approvals for new compounds over the past decade is roughly the same as it was during the previous two-and-a-half decades, when the diseases received little attention," Nature Medicine reports.
› Verified 9 days ago